Title: ADHD Medications: Risk, Bias, and Real Outcomes
Hosts: James Kennedy, PMHNP-BC & Jon Murphy, PMHNP-BC

In this first episode of Compass Point Institute, James and Jon break down a major new study published in JAMA Psychiatry (June 25, 2025) tracking ADHD medication outcomes in over 260,000 individuals.

🎯 Topics covered:

• Key findings from a 15-year longitudinal study
• Reduced self-harm, accident, and criminal risk
• Navigating stigma, DEA scrutiny, and Schedule II status
• Provider bias and the myth of “weekend breaks”
• Practical clinical guidance on stimulant prescribing
• The difference between physiological vs psychological addiction

This episode is designed to support mental health clinicians with real-world data, clear context, and grounded insight.

📬 Have a topic you want us to cover? Reach out anytime.
 🧭 Compass Point Institute — Empowering the next generation of mental health clinicians.